Creators Push For Fair Remuneration At WIPO General Assembly 29/09/2014 by Catherine Saez, Intellectual Property Watch 1 Comment Creative artists came to this week’s World Intellectual Property Organization General Assembly to encourage governments to build a sustainable future for creators and ensure fair remuneration for their work. This may mean looking for ways to redistribute the value of content.
Several WIPO Committee Reports Stamped by General Assembly; Dissent Persists 28/09/2014 by Catherine Saez and William New, Intellectual Property Watch 3 Comments Every year at this time, various World Intellectual Property Organization committees give a report to the organisation’s General Assembly on their past year’s activities and recommendations for decisions to be taken, including work they will be undertaking during the next year. At this week’s Assembly, reports were noted from committees on patents, trademarks, WIPO standards, and enforcement.
Countries Begin Push To Reduce Differences In Patent Laws 26/09/2014 by William New, Intellectual Property Watch 1 Comment Some of the leading patent-filing nations this week renewed an effort to harmonise procedures for filing patents in their national offices. Image Credits: Eric Bridiers, US Mission
Patent Landscape For Hepatitis Issued By WHO 26/09/2014 by Intellectual Property Watch Leave a Comment The World Health Organization has published an analysis of the patent situation for new hepatitis treatments, and a call for possible pharmaceutical products for prequalification.
Lisbon GI Revision A Hot Topic As Members Prepare For Treaty Talks 26/09/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment A proposed amendment to the Lisbon Agreement protecting appellations of origin at the World Intellectual Property Organization is the object of heated discussions between proponents of geographical indications and countries favouring other systems such as trademarks to protect such intellectual property titles. A side event to this week’s WIPO General Assemblies gathered GI proponents to ponder the future of the agreement.
Strengthening WIPO’s Governance For The Next 50 Years: A Time For Action 26/09/2014 by Intellectual Property Watch 1 Comment In 2017, the World Intellectual Property Organization (WIPO) will mark its 50th anniversary. In the lead up to that milestone, the next three years provide a vital opportunity for Member States to update and strengthen WIPO’s governance, both to address current problems and to better equip the organisation for addressing challenges that may arise in the next 50 years, writes Carolyn Deere Birkbeck.
Tobacco Plain Packaging Gains Ground As France Introduces Draft Bill 25/09/2014 by Catherine Saez, Intellectual Property Watch 1 Comment French Minister for Social Affairs, Health and Rights of Women Marisol Touraine today announced a national programme to reduce tobacco use in France, including plain packaging.
WIPO General Assembly Highlights Positions On Key IP Policy Issues 25/09/2014 by Catherine Saez, Intellectual Property Watch 2 Comments In the opening days of this week’s annual World Intellectual Property Organization General Assembly, member governments showed a diversity of views on issues such as negotiations for possible treaties on broadcasters’ rights, design law, copyright exceptions for libraries, and protection of traditional knowledge. But one of the biggest gaps is over the future of the WIPO Development Agenda, with some countries suggesting a new course for this agenda, and proponents deeply concerned about a loss of momentum.
Panellists Discuss Value Of Patent Pooling For HIV/AIDS, Potential For Other Diseases 25/09/2014 by William New, Intellectual Property Watch 1 Comment A side event to this week’s World Intellectual Property Organization annual General Assembly highlighted the work of the Geneva-based Medicines Patent Pool in fighting HIV/AIDS, and discussed whether it makes sense for the patent pool model to be extended to other diseases.
Gilead Monopoly Prevails Over Non-Discriminatory Access As Debated Hepatitis C Deal Sets Off 25/09/2014 by Intellectual Property Watch 2 Comments Gilead on 15 September struck voluntary licence deals with seven India-based generic manufacturers to expand access to its hepatitis C innovative drugs in developing countries. With a limited territory covered, this, yet deserving, pact raises doubts about the coherence of Indian counterparts at a time when there are no relevant patents in India, several pre-grant oppositions have been filed and unrestrained competition by compulsory licences could have been pursued, writes Daniele Dionisio.